Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 369
GE, Roche join forces
By
AuntMinnie.com staff writers
GE Healthcare and Swiss healthcare firm Roche are teaming up to explore personalized medicine in patients with Alzheimer's disease.
July 10, 2005
SPECT/CT brightens nuclear medicine's prospects
By
Brian Casey
July 6, 2005
Can SPECT/CT revitalize nuclear medicine?
By
Marvin Burns
SPECT/CT has been introduced recently with the expectation that it will emulate PET/CT's success as a hybrid imaging modality. Proponents are confident that the addition of CT will provide a new springboard for SPECT in nuclear cardiology as well as other functional studies, revitalizing traditional nuclear medicine.
July 6, 2005
Report projects rapid PET procedure growth
By
AuntMinnie.com staff writers
The demand for PET continued to grow in 2004, reaching 1 million procedures, an increase of 46% for the year. Procedure volume is expected to rise to 3.2 million procedures by 2010, according to a recent study by market research firm Bio-Tech Systems.
July 5, 2005
PET/CT provides cost-savings for NSCLC radiotherapy
By
Jonathan S. Batchelor
PET/CT technology has been demonstrating superior diagnostic and staging capabilities for various malignancies in scientific studies. But the technology comes at a steep price point, and models for its economic efficiencies are still being created. However, researchers from Canada have found PET/CT to be cost-effective in radiation therapy planning for non-small cell lung cancer (NSCLC).
July 3, 2005
PET/CT improves diagnostic accuracy of unexpected malignancies
By
N. Shivapriya
The use of PET/CT can decrease uncertainty and improve diagnostic accuracy in 18-F FDG-PET studies to detect unexpected malignancies, according to two recent studies in the
Journal of Nuclear Medicine
.
June 29, 2005
Radiopharmaceuticals market to reach $3.2 billion by 2010
By
AuntMinnie.com staff writers
The overall U.S. market for diagnostic radiopharmaceuticals reached $1.53 billion in 2004 and is expected to rise to $3.2 billion by 2010, according to a recent study by market research firm Bio-Tech Systems.
June 28, 2005
Multiple modalities show similar results for initial staging of head and neck cancer
By
Jonathan S. Batchelor
TORONTO - Head and neck cancer is the fifth most common cancer worldwide and accounts for 2.8% of all malignancies in the U.S., according to presentations this week at the Society of Nuclear Medicine (SNM) conference. Multimodality management of head and neck cancer patients is now the modus operandi in most medical centers.
June 22, 2005
Cedara inks molecular software deal
By
AuntMinnie.com staff writers
Merge Healthcare's Cedara Software division has signed an agreement with Molecular Therapeutics of Ann Arbor, MI, to market and sell software for functional diffusion mapping.
June 21, 2005
Coronary PET links obesity to endothelial dysfunction, increased FDG uptake
By
Jonathan S. Batchelor
TORONTO - Obesity is associated with abnormal coronary circulatory function and increases FDG uptake in large arteries, according to a pair of presentations at the Society of Nuclear Medicine (SNM) meeting this week.
June 21, 2005
SNM taps Conti as president
Dr. Peter Conti, Ph.D, will serve as president of the Society of Nuclear Medicine (SNM) until June 2006.
June 20, 2005
Cytogen cites promising results for cancer pain medication
By
AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen announced the results of a study that evaluated the use of its nonopioid therapeutic pain medication alone and in conjunction with chemotherapy for the treatment of prostate, breast, lung, and other cancers.
June 20, 2005
Previous Page
Page 369 of 439
Next Page
